Manufacture of test and automation systems for medical laboratory diagnostics
Euroimmun Medizinische Labordiagnostika AG
New on Amplifa
About Euroimmun
Euroimmun Medizinische Labordiagnostika AG (EUROIMMUN) is a company founded in 1987 by Winfried Stöcker and headquartered in Lübeck that manufactures reagents and test systems for medical laboratory diagnostics. The focus is on test systems for determining antibodies in patient serum for the diagnosis of autoimmune and infectious diseases (including COVID-19) as well as allergies. The portfolio includes, among other things, ELISA test systems, immunofluorescence tests based on the company's own biochip technology, as well as software and automation systems for performing and evaluating the tests. The biochips are paper-thin glass films coated with cells or tissue sections, mechanically divided into millimeter-sized fragments and fully automatically bonded to microscope slides. Since 2017 the company has belonged to PerkinElmer and, since 2023, to its successor Revvity; via its sister company Immunodiagnostic Systems (IDS), the ChLIA automation platform is also offered. With around 3500 employees in 17 countries, Euroimmun supplies laboratories, hospitals, health authorities and academic institutions in over 140 countries.
- Site
- Lübeck
- Processes
- Automation systems, Software for test execution and evaluation, Euroimmun Academy (further education/training), Technical customer service (Customer Technical Operations)
- Materials
- ELISA test systems, Biochip technology, ChLIA automation platform (IDS), Software for test execution and evaluation
- Certificates
- IVDD/IVDR compliance (EU Regulation 2024/1860, deadline extension confirmed), IVDD/IVDR compliance (EU Regulation 2024/1860)
- Founded
- 1987
- Employees
- 3500
- Industries
- Medical laboratory diagnostics, Biotechnology, Medical technology
- 01
Development of test systems and assays
- 02
Manufacture of reagents and biochips
- 03
Production of automation systems
- 04
Software development for test execution and evaluation
- 05
Customer Technical Operations (technical customer service)
- 06
Training and further education (Euroimmun Academy)
- 07
Sales via 16 branches worldwide
Products and Technologies
ELISA test systems
Enzyme immunoassays for the detection of antibodies in autoimmune and infectious diseases as well as allergies.
Biochip technology
Glass films coated with cells or tissue sections in millimeter-sized fragments for standardized immunofluorescence diagnostics.
ChLIA automation platform (IDS)
Random-access platform for the automated execution and evaluation of chemiluminescence-based immunoassays.
Software for test execution and evaluation
Software solutions supporting test execution and results assessment in the laboratory.
Inside the production
Industries
Additional services
Reference customers
Quality and Regulatory Affairs
All in vitro diagnostics are subject to EU regulation; in June 2026 TÜV Rheinland LGA Products GmbH confirmed the extension of the sales deadline under EU Regulation 2024/1860 until 2029.
| Evidence | Lübeck |
|---|---|
| IVDD/IVDR compliance (EU Regulation 2024/1860) |
History
- 1987
Founded by Winfried Stöcker in Lübeck
- 1989
Schmidt-Römhild Technology Prize for biochip technology
- 2017
Acquisition by PerkinElmer for €1.2 billion completed (antitrust approval August 2017)
- 2019
Wolfgang Schlumberger takes over as Chairman of the Management Board
- 2023
PerkinElmer's Life Sciences and Diagnostics divisions become Revvity; Dirk Beecker succeeds Schlumberger as Chairman of the Management Board
- 2025
Around 3500 employees worldwide, over 900 in Lübeck; job cuts are emerging